| Serial Number | 88086496 |
| Word Mark | GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML) |
| Filing Date | Tuesday, August 21, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 6, 2020 |
| Registration Number | 6169996 |
| Registration Date | Tuesday, October 6, 2020 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 29, 2019 |
| Indication of Colors claimed | The color(s) brown, white and black is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML) |
| Description of Mark | The mark consists of a brown outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" along with a brown arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in brown, with the words "1,200 mg per 120 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark. |
| Goods and Services | medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine |
| Goods and Services | medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine |
| Pseudo Mark | GEMCITABINE IN 0. NINE PERCENT SODIUM CHLORIDE INJECTION ONE, THOUSAND TWO HUNDRED MG PER ONE HUNDRED ML (TEN MG/ML) |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 29, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, July 8, 2020 |
| First Use In Commerce Date | Wednesday, July 8, 2020 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 29, 2018 |
| Primary Code | 010 |
| First Use Anywhere Date | Wednesday, July 8, 2020 |
| First Use In Commerce Date | Wednesday, July 8, 2020 |
| Party Name | Sun Pharmaceutical Industries Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mumbai, Maharashtra 400063 IN |
| Party Name | Sun Pharmaceutical Industries Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mumbai, Maharashtra 400063 IN |
| Party Name | Sun Pharmaceutical Industries Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mumbai, Maharashtra 400063 IN |
| Event Date | Event Description |
| Tuesday, October 6, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, September 3, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, September 2, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, August 13, 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, August 4, 2020 | USE AMENDMENT FILED |
| Thursday, August 13, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, August 4, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Friday, March 20, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 18, 2020 | EXTENSION 2 GRANTED |
| Wednesday, March 18, 2020 | EXTENSION 2 FILED |
| Wednesday, March 18, 2020 | TEAS EXTENSION RECEIVED |
| Saturday, September 21, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 19, 2019 | EXTENSION 1 GRANTED |
| Thursday, September 19, 2019 | EXTENSION 1 FILED |
| Thursday, September 19, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, March 26, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 29, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 29, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 9, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, December 21, 2018 | ASSIGNED TO LIE |
| Thursday, November 29, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 29, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 29, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 29, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 29, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, November 27, 2018 | ASSIGNED TO EXAMINER |
| Thursday, August 30, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, August 29, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, August 24, 2018 | NEW APPLICATION ENTERED IN TRAM |